Another study found that CXCL12/CXCR4 signal axis activated HER2 through SRC, promoting the growth and proliferation of breast cancer cells, so that MCF‐7 cells have resistance to tamoxifen.85 This evidence concerns the gene CXCR4 and breast carcinoma.